Related Experiment Videos
Antiproliferative effect of multiple autocrine loop blockade in human malignant glioma cell lines
M Kurimoto1, K Nogami, T Ogiichi
1Department of Neurosurgery, Toyama Medical and Pharmaceutical University, Faculty of Medicine.
Abstract:
The effects of specific antibodies against growth factors and receptors on deoxyribonucleic acid (DNA) synthesis in two established human glioma cell lines, A172 and TM-1, were examined. Anti-platelet-derived growth factor (PDGF), anti-basic fibroblast growth factor (bFGF), and anti-epidermal growth factor receptor (EGF-R) antibodies inhibited thymidine incorporation by both cell lines in serum-free medium. Antibody specific to transforming growth factor-alpha only slightly suppressed DNA synthesis by both cell lines. Although the antiproliferative effects of anti-PDGF and anti-bFGF antibodies decreased in serum-supplemented medium, the effect of anti-EGF-R antibody was little changed. The combination of anti-PDGF, anti-bFGF, and anti-EGF-R antibodies significantly inhibited thymidine incorporation by the two cell lines even in serum-supplemented medium. This preliminary study suggests that simultaneous blockade of multiple autocrine loops may provide a new approach to the treatment of human malignant gliomas.
Insights
Antibodies targeting growth factors and receptors like PDGF, bFGF, and EGF-R can inhibit glioma cell growth. Blocking multiple growth pathways simultaneously shows promise for treating malignant gliomas.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Malignant gliomas are aggressive brain tumors with limited treatment options.
- Growth factors and their receptors play crucial roles in glioma cell proliferation and survival.
- Autocrine signaling loops involving growth factors are implicated in glioma pathogenesis.
Purpose of the Study:
- To investigate the effects of specific antibodies against growth factors and receptors on DNA synthesis in human glioma cell lines.
- To evaluate the efficacy of blocking individual and multiple growth factor pathways in vitro.
Main Methods:
- Utilized two human glioma cell lines (A172 and TM-1).
- Assessed the impact of antibodies against platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), epidermal growth factor receptor (EGF-R), and transforming growth factor-alpha on thymidine incorporation (DNA synthesis).
- Conducted experiments in both serum-free and serum-supplemented media.
Main Results:
- Anti-PDGF, anti-bFGF, and anti-EGF-R antibodies significantly inhibited thymidine incorporation in both cell lines in serum-free conditions.
- Anti-transforming growth factor-alpha antibody showed only a slight suppression of DNA synthesis.
- While anti-PDGF and anti-bFGF effects diminished in serum-supplemented medium, anti-EGF-R antibody efficacy remained largely unchanged.
- Combined blockade of PDGF, bFGF, and EGF-R pathways resulted in significant inhibition of DNA synthesis even in serum-supplemented medium.
Conclusions:
- Specific antibodies targeting PDGF, bFGF, and EGF-R can inhibit DNA synthesis in human glioma cells.
- Simultaneous blockade of multiple autocrine growth factor loops demonstrates potent antiproliferative effects.
- Targeting multiple growth pathways concurrently represents a potential therapeutic strategy for human malignant gliomas.